Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Picornaviral Research Unit

Discipline of Immunology and Microbiology

Faculty of Medicine and Health Sciences

University of Newcastle

Australia

Name/email consistency: high

Picornaviral Research Unit, Discipline of Immunology and Microbiology, Faculty of Medicine and Health Sciences, University of Newcastle, Australia. 1999 - 2005
Department of Microbiology, Faculty of Medicine, The University of Newcastle, Australia. 1997 - 1998

Oncolysis of human ovarian cancers by echovirus type 1. Shafren, D.R., Sylvester, D., Johansson, E.S., Campbell, I.G., Barry, R.D. Int. J. Cancer (2005) [Pubmed]
Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. Shafren, D.R., Dorahy, D.J., Thorne, R.F., Barry, R.D. J. Gen. Virol. (2000) [Pubmed]
Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2. Shafren, D.R., Gardner, J., Mann, V.H., Antalis, T.M., Suhrbier, A. J. Virol. (1999) [Pubmed]
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. Shafren, D.R., Dorahy, D.J., Thorne, R.F., Kinoshita, T., Barry, R.D., Burns, G.F. J. Immunol. (1998) [Pubmed]
Viral cell entry induced by cross-linked decay-accelerating factor. Shafren, D.R. J. Virol. (1998) [Pubmed]
A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. Shafren, D.R., Williams, D.T., Barry, R.D. J. Virol. (1997) [Pubmed]